NM_004153.4:c.2314G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004153.4(ORC1):​c.2314G>A​(p.Val772Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00579 in 1,612,708 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V772L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0048 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 39 hom. )

Consequence

ORC1
NM_004153.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: -1.02

Publications

8 publications found
Variant links:
Genes affected
ORC1 (HGNC:8487): (origin recognition complex subunit 1) The origin recognition complex (ORC) is a highly conserved six subunits protein complex essential for the initiation of the DNA replication in eukaryotic cells. Studies in yeast demonstrated that ORC binds specifically to origins of replication and serves as a platform for the assembly of additional initiation factors such as Cdc6 and Mcm proteins. The protein encoded by this gene is the largest subunit of the ORC complex. While other ORC subunits are stable throughout the cell cycle, the levels of this protein vary during the cell cycle, which has been shown to be controlled by ubiquitin-mediated proteolysis after initiation of DNA replication. This protein is found to be selectively phosphorylated during mitosis. It is also reported to interact with MYST histone acetyltransferase 2 (MyST2/HBO1), a protein involved in control of transcription silencing. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]
ORC1 Gene-Disease associations (from GenCC):
  • Meier-Gorlin syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Meier-Gorlin syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065743923).
BP6
Variant 1-52374887-C-T is Benign according to our data. Variant chr1-52374887-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 297579.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00475 (724/152282) while in subpopulation NFE AF = 0.00657 (447/68026). AF 95% confidence interval is 0.00607. There are 1 homozygotes in GnomAd4. There are 372 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 39 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ORC1NM_004153.4 linkc.2314G>A p.Val772Ile missense_variant Exon 16 of 17 ENST00000371568.8 NP_004144.2 Q13415

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ORC1ENST00000371568.8 linkc.2314G>A p.Val772Ile missense_variant Exon 16 of 17 1 NM_004153.4 ENSP00000360623.3 Q13415
ORC1ENST00000371566.1 linkc.2314G>A p.Val772Ile missense_variant Exon 16 of 17 1 ENSP00000360621.1 Q13415

Frequencies

GnomAD3 genomes
AF:
0.00475
AC:
723
AN:
152164
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0193
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00657
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00489
AC:
1228
AN:
251312
AF XY:
0.00498
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0188
Gnomad NFE exome
AF:
0.00647
Gnomad OTH exome
AF:
0.00440
GnomAD4 exome
AF:
0.00590
AC:
8620
AN:
1460426
Hom.:
39
Cov.:
30
AF XY:
0.00574
AC XY:
4170
AN XY:
726668
show subpopulations
African (AFR)
AF:
0.000837
AC:
28
AN:
33450
American (AMR)
AF:
0.00141
AC:
63
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.000498
AC:
13
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86232
European-Finnish (FIN)
AF:
0.0168
AC:
895
AN:
53412
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
0.00661
AC:
7337
AN:
1110702
Other (OTH)
AF:
0.00459
AC:
277
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
375
749
1124
1498
1873
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00475
AC:
724
AN:
152282
Hom.:
1
Cov.:
32
AF XY:
0.00500
AC XY:
372
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00103
AC:
43
AN:
41556
American (AMR)
AF:
0.00157
AC:
24
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.0193
AC:
205
AN:
10602
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00657
AC:
447
AN:
68026
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
38
75
113
150
188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00476
Hom.:
4
Bravo
AF:
0.00339
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00778
AC:
30
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00593
AC:
51
ExAC
AF:
0.00455
AC:
552
EpiCase
AF:
0.00562
EpiControl
AF:
0.00551

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ORC1: BP4, BS2 -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meier-Gorlin syndrome 1 Benign:2Other:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Sep 29, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

not specified Benign:1
Apr 19, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ORC1-related disorder Benign:1
Jun 27, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
6.8
DANN
Benign
0.84
DEOGEN2
Benign
0.0084
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.61
.;T
MetaRNN
Benign
0.0066
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;L
PhyloP100
-1.0
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.21
N;N
REVEL
Benign
0.047
Sift
Benign
0.46
T;T
Sift4G
Benign
0.56
T;T
Polyphen
0.0
B;B
Vest4
0.077
MVP
0.17
MPC
0.12
ClinPred
0.0046
T
GERP RS
-0.62
Varity_R
0.076
gMVP
0.067
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61753389; hg19: chr1-52840559; COSMIC: COSV99056456; API